# Wandercraft gets FDA clearance for Eve, a self-balancing exoskeleton for wheelchair users with spinal cord injuries

Canonical page: https://technooptimist.io/stories/wandercraft-gets-fda-clearance-for-eve-a-self-balancing-exoskeleton-for-5e9d98cf
Date: 11 Aug 2026
About: [Wandercraft](https://technooptimist.io/companies/wandercraft.md) · [Eve](https://technooptimist.io/robotics/eve.md)
Original source: https://www.manilatimes.net/2026/08/11/tmt-newswire/globenewswire/wandercraft-receives-fda-clearance-for-eve-the-worlds-first-self-balancing-personal-exoskeleton-for-eligible-wheelchair-users-living-with-spinal-cord-injuries-at-any-level/2403113

The FDA cleared Eve, Wandercraft's self-balancing personal exoskeleton, for eligible adults with spinal cord injuries at any neurological level, the company announced on August 11, 2026. The clearance followed a clinical trial at three sites in New York and New Jersey, where the company says participants met key functional and usability endpoints.

## Key facts

- Eligible users need a prescription, a clinical assessment, an individual fitting and five two-hour training sessions with a companion.
- Intended use is on level indoor floors and nearby open-air areas such as patios, under a trained companion's supervision.
- Wandercraft expects Medicare reimbursement eligibility within 60 to 90 days; Medicare covers qualifying personal exoskeletons under HCPCS code K1007.
- The company said the US commercial launch was planned for September 17, 2026, with a wider fall rollout through distribution partners.

---

The Techno Optimist tracks every frontier of technology, program by program: https://technooptimist.io/ (a Markdown version of any page: add .md to its URL; site map for agents: https://technooptimist.io/llms.txt).
Data API (JSON, realtime stream): https://technooptimist.io/developers. People read 5 pages free, then Reader $10/month; these Markdown pages are open to agents.